NASDAQ:TRIB Trinity Biotech (TRIB) Stock Forecast, Price & News $1.04 +0.08 (+8.33%) (As of 06/8/2023 ET) Add Compare Share Share Today's Range$0.96▼$1.1050-Day Range$0.84▼$1.1452-Week Range$0.80▼$1.50Volume294,953 shsAverage Volume32,362 shsMarket Capitalization$39.63 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Trinity Biotech MarketRank™ ForecastAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.08% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.43Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.22) to $0.14 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.45 out of 5 starsMedical Sector911th out of 986 stocksDiagnostic Substances Industry13th out of 15 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Trinity Biotech. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.08% of the outstanding shares of Trinity Biotech have been sold short.Short Interest Ratio / Days to CoverTrinity Biotech has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Trinity Biotech has recently decreased by 18.33%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldTrinity Biotech does not currently pay a dividend.Dividend GrowthTrinity Biotech does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRIB. Previous Next 2.5 News and Social Media Coverage News SentimentTrinity Biotech has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Trinity Biotech this week, compared to 1 article on an average week.MarketBeat Follows1 people have added Trinity Biotech to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Trinity Biotech insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.20% of the stock of Trinity Biotech is held by insiders.Percentage Held by InstitutionsOnly 18.41% of the stock of Trinity Biotech is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Trinity Biotech are expected to grow in the coming year, from ($0.22) to $0.14 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Trinity Biotech is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Trinity Biotech is -0.81, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Trinity Biotech (NASDAQ:TRIB) StockTrinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.Read More Receive TRIB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address TRIB Stock News HeadlinesJune 3, 2023 | finance.yahoo.comCalculating The Intrinsic Value Of Trinity Biotech plc (NASDAQ:TRIB)June 3, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Earns Buy Rating from Analysts at StockNews.comJune 9, 2023 | UNKNOWN (Ad)Lithium Has Boomed And This American Stock Is Ready..Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!June 2, 2023 | msn.comTrinity Biotech to add up to 40 news jobs at Wicklow headquartersMay 29, 2023 | americanbankingnews.comHead-To-Head Comparison: Lucira Health (NASDAQ:LHDXQ) and Trinity Biotech (NASDAQ:TRIB)May 26, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.comMay 18, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Receives New Coverage from Analysts at StockNews.comMay 9, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.comJune 9, 2023 | UNKNOWN (Ad)Lithium Has Boomed And This American Stock Is Ready..Lithium Has Been On A Crazy Rally Over The Last 3 Year's And This Stock Could Be Next!May 5, 2023 | finance.yahoo.comTrinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleMay 1, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Coverage Initiated by Analysts at StockNews.comApril 29, 2023 | americanbankingnews.comTrinity Biotech plc (NASDAQ:TRIB) Sees Significant Growth in Short InterestApril 28, 2023 | finanznachrichten.deTrinity Biotech plc: Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to BiosynthApril 27, 2023 | finance.yahoo.comTrinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to BiosynthApril 24, 2023 | finance.yahoo.comTrinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price RequirementApril 24, 2023 | americanbankingnews.comCardio Diagnostics (NASDAQ:CDIO) versus Trinity Biotech (NASDAQ:TRIB) Head-To-Head ReviewApril 23, 2023 | finance.yahoo.comThis Trinity Biotech plc (NASDAQ:TRIB) Analyst Is Way More Bearish Than They Used To BeApril 20, 2023 | finanznachrichten.deTrinity Biotech plc: Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to BiosynthApril 20, 2023 | benzinga.comWhy Trinity Biotech Stock Is Moving Up TodayApril 16, 2023 | americanbankingnews.comTrinity Biotech (NASDAQ:TRIB) Coverage Initiated at StockNews.comApril 9, 2023 | msn.comPennsylvania Biotech Center In Doylestown Launches PodcastApril 9, 2023 | msn.comTrinity Biotech writes down value of two Covid tests to zero, with demand ‘highly uncertain’March 27, 2023 | insidermonkey.comTrinity Biotech plc (NASDAQ:TRIB) Q4 2022 Earnings Call TranscriptMarch 25, 2023 | finance.yahoo.comWhat Is Trinity Biotech plc's (NASDAQ:TRIB) Share Price Doing?March 23, 2023 | finance.yahoo.comTrinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial ResultsMarch 22, 2023 | marketwatch.comTrinity Biotech Welcomes TrinScreen HIV's Inclusion In The New Kenyan HIV Testing AlgorithmMarch 22, 2023 | finance.yahoo.comTrinity Biotech Welcomes TrinScreen HIV’s Inclusion In The New Kenyan HIV Testing AlgorithmSee More Headlines TRIB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TRIB Company Calendar Last Earnings3/23/2023Today6/08/2023Next Earnings (Estimated)6/29/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Diagnostic substances Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRIB CUSIPN/A CIK888721 Webwww.trinitybiotech.com Phone(531) 276-9800Fax353-1276-9888Employees543Year Founded1992Profitability EPS (Most Recent Fiscal Year)($1.29) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-41,010,000.00 Net Margins-54.84% Pretax Margin-55.09% Return on Equity-724.07% Return on Assets-25.12% Debt Debt-to-Equity Ratio8.70 Current Ratio2.69 Quick Ratio1.39 Sales & Book Value Annual Sales$74.78 million Price / Sales0.53 Cash FlowN/A Price / Cash FlowN/A Book Value($0.06) per share Price / Book-17.33Miscellaneous Outstanding Shares38,110,000Free Float34,983,000Market Cap$39.63 million OptionableOptionable Beta1.41 Social Links Key ExecutivesAris KekedjianChairman & Chief Executive OfficerJohn GillardCFO, Secretary & Executive DirectorEibhlin KellyChief Information OfficerTerence DunneDirector-Business DevelopmentFernando DeviaExecutive Vice President-SalesKey CompetitorsNymox PharmaceuticalNASDAQ:NYMXOncoCyteNASDAQ:OCXImmuCellNASDAQ:ICCCAspira Women's HealthNASDAQ:AWHBiomericaNASDAQ:BMRAView All CompetitorsInstitutional OwnershipRenaissance Technologies LLCSold 16,540 shares on 5/12/2023Ownership: 3.613%Aristides Capital LLCSold 57,213 shares on 5/12/2023Ownership: 0.426%Envestnet Asset Management Inc.Sold 47,358 shares on 5/11/2023Ownership: 0.139%Hunter Associates Investment Management LLCSold 48,533 shares on 5/2/2023Ownership: 4.658%View All Institutional Transactions TRIB Stock - Frequently Asked Questions How have TRIB shares performed in 2023? Trinity Biotech's stock was trading at $0.99 at the start of the year. Since then, TRIB stock has increased by 5.1% and is now trading at $1.04. View the best growth stocks for 2023 here. Are investors shorting Trinity Biotech? Trinity Biotech saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 29,400 shares, a decrease of 18.3% from the April 30th total of 36,000 shares. Based on an average daily trading volume, of 36,200 shares, the days-to-cover ratio is currently 0.8 days. View Trinity Biotech's Short Interest. When is Trinity Biotech's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023. View our TRIB earnings forecast. How were Trinity Biotech's earnings last quarter? Trinity Biotech plc (NASDAQ:TRIB) announced its earnings results on Thursday, March, 23rd. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.12. The company had revenue of $18.04 million for the quarter, compared to the consensus estimate of $18 million. Trinity Biotech had a negative net margin of 54.84% and a negative trailing twelve-month return on equity of 724.07%. What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO? 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Trinity Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM). What is Trinity Biotech's stock symbol? Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB." Who are Trinity Biotech's major shareholders? Trinity Biotech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Hunter Associates Investment Management LLC (4.66%), Renaissance Technologies LLC (3.61%), Aristides Capital LLC (0.43%), Envestnet Asset Management Inc. (0.14%) and Group One Trading L.P. (0.00%). How do I buy shares of Trinity Biotech? Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Trinity Biotech's stock price today? One share of TRIB stock can currently be purchased for approximately $1.04. How much money does Trinity Biotech make? Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $39.63 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis. How many employees does Trinity Biotech have? The company employs 543 workers across the globe. How can I contact Trinity Biotech? Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888. This page (NASDAQ:TRIB) was last updated on 6/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.